Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Obstetrics and Gynecology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The effect of progesterone on the human uterus.Proc Natl Acad Sci U S A. 1965; 54: 1069-1076
- What we have learned about the role of 17-alpha-hydroxyprogesterone caproate in the prevention of preterm birth.Semin Perinatol. 2016; 40: 273-280
- Direct transport of progesterone from vagina to uterus.Obstet Gynecol. 2000; 95 (Available at:) (Accessed October 3, 2017): 403-406
- Pharmacokinetics of Vaginal Progesterone in Pregnancy.Am J Obstet Gynecol. 2019; 221https://doi.org/10.1016/j.ajog.2019.06.019
- Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: A critical examination of efficacy and safety.Am J Obstet Gynecol. 2016; 214: 45-56
- Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials.Lancet. 2021; 397: 1183-1194
- Single and multidose pharmacokinetic study of a vaginal micronized progesterone insert (Endometrin) compared with vaginal gel in healthy reproductive-aged female subjects.Fertil Steril. 2010; 94: 1296-1301
- Oral progesterone for the prevention of recurrent preterm birth: systematic review and metaanalysis.Am J Obstet Gynecol MFM. 2019; 1: 50-62
- Prevention of preterm birth by progestational agents: what are the molecular mechanisms?.Am J Obstet Gynecol. 2013; 208: 223.e1-223.e7
- Replens prevents preterm birth by decreasing type I interferon strengthening the cervical epithelial barrier.Am J Reprod Immunol. 2020; 83https://doi.org/10.1111/aji.13192
- Progesterone inhibits in vitro fetal membrane weakening.Am J Obstet Gynecol. 2015; 213 (Mosby Inc): 520.e1-520.e9
- Vaginal progesterone, but not 17-ahydroxyprogesterone caproate, has antiinflammatory effects at the murine maternal-fetal interface.Am J Obstet Gynecol. 2015; 213 (Vaginal): e1-e35
- PROMISE: First-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages – A randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation.Health Technol Assess (Rockv). 2016; 20: 7-91
- Progesterone to prevent miscarriage in women with early pregnancy bleeding: The PRISM RCT.Health Technol Assess (Rockv). 2020; 24: 1-70
- Progestogens for preventing miscarriage: a network meta-analysis.Cochrane Database Syst Rev. 2021; 2021https://doi.org/10.1002/14651858.CD013792.pub2
- Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence.Am J Obstet Gynecol. 2020; 223: 167-176
- Vaginal progesterone, oral progesterone, 17-OHPC, cerclage, and pessary for preventing preterm birth in at-risk singleton pregnancies: an updated systematic review and network meta-analysis.BJOG An Int J Obstet Gynaecol. 2019; 126: 556-567
- Vaginal progesterone compared with intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in singleton gestations: a systematic review and meta-analysis.Am J Obstet Gynecol MFM. 2022; 4https://doi.org/10.1016/j.ajogmf.2022.100658
- Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234.Obstet Gynecol. 2021; 138: e65-e90
- Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.N Engl J Med. 2003; 348: 2379-2385
- 17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial.Am J Perinatol. 2019; 1https://doi.org/10.1055/s-0039-3400227
- SMFM Statement: Use of 17-Alpha Hydroxyprogesterone Caproate for Prevention of Recurrent Preterm Birth.(Accessed November 15, 2022)
- Vaginal versus Intramuscular Progesterone for Prevention of Recurrent Preterm Birth (VIP): a randomized controlled trial.Am J Obstet Gynecol. 2022; 226: S26
- Vaginal Progesterone for Preventing Preterm Birth and Adverse Perinatal Outcomes in Singleton Gestations with a Short Cervix: A Meta-Analysis of Individual Patient Data.Am J Obstet Gynecol. 2018; 218: 161-180
- Vaginal progesterone for the prevention of preterm birth and adverse perinatal outcomes in twin gestations with a short cervix: an updated individual patient data meta-analysis.Ultrasound Obstet Gynecol. 2022; 59: 263-266
- Intramuscular progesterone in women with twins and a prior singleton spontaneous preterm birth.Am J Obstet Gynecol MFM. 2020; 2 (Elsevier Inc)https://doi.org/10.1016/j.ajogmf.2020.100124
- Progestational agents for treating threatened or established preterm labour.Cochrane Database Syst Rev. 2014; https://doi.org/10.1002/14651858.CD006770.pub3
- GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables..J Clin Epidemiol. 2011; 64: 383-394
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
